Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma

M V Maraldo; N P Brodin; M C Aznar; I R Vogelius; P Munck af Rosenschöld; P M Petersen; L Specht

doi:10.1093/annonc/mdt156

Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma

M V Maraldo, N P Brodin, M C Aznar, I R Vogelius, P Munck af Rosenschöld, P M Petersen, L Specht

120 Citations (Scopus)

Abstract

Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF).

Original language	English
Journal	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	24
Issue number	8
Pages (from-to)	2113-8
Number of pages	6
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdt156
Publication status	Published - 24 Aug 2013

Access to Document

10.1093/annonc/mdt156

Cite this

Maraldo, M. V., Brodin, N. P., Aznar, M. C., Vogelius, I. R., Munck af Rosenschöld, P., Petersen, P. M., & Specht, L. (2013). Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 24(8), 2113-8. https://doi.org/10.1093/annonc/mdt156

Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. / Maraldo, M V; Brodin, N P; Aznar, M C et al.

In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, No. 8, 24.08.2013, p. 2113-8.

Research output: Contribution to journal › Journal article › Research › peer-review

Maraldo, MV, Brodin, NP, Aznar, MC, Vogelius, IR, Munck af Rosenschöld, P, Petersen, PM & Specht, L 2013, 'Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 24, no. 8, pp. 2113-8. https://doi.org/10.1093/annonc/mdt156

Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af Rosenschöld P, Petersen PM et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Aug 24;24(8):2113-8. https://doi.org/10.1093/annonc/mdt156

@article{a943909187994a65a2e397f6924d4443,

title = "Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma",

abstract = "Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF).",

author = "Maraldo, {M V} and Brodin, {N P} and Aznar, {M C} and Vogelius, {I R} and {Munck af Rosensch{\"o}ld}, P and Petersen, {P M} and L Specht",

year = "2013",

month = aug,

day = "24",

doi = "10.1093/annonc/mdt156",

language = "English",

volume = "24",

pages = "2113--8",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma

AU - Maraldo, M V

AU - Brodin, N P

AU - Aznar, M C

AU - Vogelius, I R

AU - Munck af Rosenschöld, P

AU - Petersen, P M

AU - Specht, L

PY - 2013/8/24

Y1 - 2013/8/24

N2 - Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF).

AB - Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF).

U2 - 10.1093/annonc/mdt156

DO - 10.1093/annonc/mdt156

M3 - Journal article

C2 - 23619032

VL - 24

SP - 2113

EP - 2118

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -

Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma

Abstract

Access to Document

Fingerprint

Cite this